Pharming Group NV announced that at its AGM, the shareholders approved the appointment of Paul Sekhri who succeeds Jaap Blaak, who is stepping down after eight years as Chairman of the BOSD. Mr. Blaak will continue to serve on the BOSD. Mr. Sekhri joined the BOSD at last years' AGM. He has 30 years of operational experience in life sciences with in-depth knowledge of multinational pharmaceutical and biotechnology markets and products.